An experimental Alzheimer s drug could be approved next year But it comes with risks weaa.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from weaa.org Daily Mail and Mail on Sunday newspapers.
Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better treatments of the incurable disease.
An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening — but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives.